ArticleFrontiers in microbiology2025
Meta-analysis of global prevalence of hepatitis E virus infection in deer.
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hepatitis E virus (HEV) is an important zoonotic pathogen, and deer serve as a potential wildlife reservoir capable of contributing to human infections through wildlife-livestock-human transmission pathways. Accurate estimates of HEV prevalence in deer are essential for understanding zoonotic risks and informing surveillance strategies. Methods: We conducted a systematic search across five major databases. Among 134 publications screened, 33 studies met the inclusion criteria for meta-analysis. Pooled prevalence estimates were calculated, and subgroup analyses were performed by region, development status, time period, age, sex, and diagnostic method. Serological assays (ELISA) and molecular assays (RT-PCR and RT-qPCR) were evaluated separately. Results: Significant geographical and demographic variation in HEV prevalence was observed. North America showed the highest pooled prevalence (29.57%, 95% CI: 0.00-89.25), with Mexico reporting the highest national estimate (62.68%, 95% CI: 54.54-70.47). Developing countries exhibited higher prevalence (21.45%, 95% CI: 7.12-40.63) than developed countries (5.01%, 95% CI: 2.40-8.43). HEV infection decreased over time, with lower prevalence after 2010 (4.92%, 95% CI: 1.57-9.83) compared with before 2010 (13.17%, 95% CI: 6.01-22.45). Adults had higher infection rates (23.02%, 95% CI: 9.04-41.06) than juveniles (10.11%, 95% CI: 5.83-15.41), and females slightly exceeded males (6.25% vs. 5.07%). Serology indicated past exposure (10.48%, 95% CI: 4.29-18.92), while molecular methods reflected active infection, with pooled rates of 8.58% for RT-PCR and 5.22% for RT-qPCR. Discussion: Our findings reveal substantial heterogeneity in HEV prevalence among deer and highlight the importance of standardized diagnostic protocols. These results underscore the need for harmonized surveillance to better assess zoonotic risks and support public health strategies targeting HEV transmission at the wildlife-human interface.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.